Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIPPET inhibitor development trial in previously untreated or minimally treated hemophilia A patients
2009-011186-88Phase 4Terminated
- Sponsor
- Fondazione Angelo Bianchi Bonomi
- Start
- Jun 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of plasma-derived factor VIII + von Willebrand factor concentrate and recombinant human coagulation factor VIII in hemophilia A (2 arms), sponsored by Fondazione Angelo Bianchi Bonomi. Started Jun 2009; status: terminated.
02
Drugs
plasma-derived factor VIII + von Willebrand factor concentraterecombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2009-011186-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011186-88.